Paper
Organic & Biomolecular Chemistry
active on the ATP synthase of Mycobacterium tuberculosis,
Science, 2005, 307, 223–227.
6 N. Willand, B. Dirié, X. Carette, P. Bifani, A. Singhal,
M. Desroses, F. Leroux, E. Willery, V. Mathys, R. Déprez-
Poulain, G. Delcroix, F. Frénois, M. Aumercier, C. Locht,
C. Locht, P. Brodin, B. Déprez, A. R. Baulard and
N. Willand, Ethionamide Boosters. 2. Combining bio-
isosteric replacement and structure-based drug design to
solve pharmacokinetic issues in a series of potent 1,2,4-
oxadiazole EthR inhibitors, J. Med. Chem., 2012, 55, 68–83.
V. Villeret, B. Déprez and A. R. Baulard, Synthetic EthR 14 B. Villemagne, M. Flipo, N. Blondiaux, C. Crauste,
inhibitors boost antituberculous activity of ethionamide,
Nat. Med., 2009, 15, 537–544.
7 F. Wang, R. Langley, G. Gulten, L. G. Dover, G. S. Besra,
W. R. Jacobs Jr. and J. C. Sacchettini, Mechanism of thio-
amide drug action against tuberculosis and leprosy, J. Exp.
Med., 2007, 204, 73–78.
S. Malaquin, F. Leroux, C. Piveteau, V. Villeret, P. Brodin,
B. O. Villoutreix, O. Sperandio, S. H. Soror, A. Wohlkönig,
R. Wintjens, B. Déprez, A. R. Baulard and N. Willand,
Ligand efficiency driven design of new inhibitors of Myco-
bacterium tuberculosis transcriptional repressor EthR
using fragment growing, merging, and linking approaches,
J. Med. Chem., 2014, 57, 4876–4888.
8 A. Bhatt, V. Molle, G. S. Besra, W. R. Jacobs Jr. and
L. Kremer, The Mycobacterium tuberculosis FAS-II conden- 15 M.-C. Lo, A. Aulabaugh, G. Jin, R. Cowling, J. Bard,
sing enzymes: their role in mycolic acid biosynthesis, acid-
fastness, pathogenesis and in future drug development,
Mol. Microbiol., 2007, 64, 1442–1454.
M. Malamas and G. Ellestad, Evaluation of fluorescence-
based thermal shift assays for hit identification in drug dis-
covery, Anal. Biochem., 2004, 332, 153–159.
9 A. R. Baulard, J. C. Betts, J. Engohang-Ndong, S. Quan, 16 J. L. Holgate and W. H. J. Ward, Measurements of binding
R. A. McAdam, P. J. Brennan, C. Locht and G. S. Besra, Acti-
vation of the pro-drug ethionamide is regulated in myco-
bacteria, J. Biol. Chem., 2000, 275, 28326–28331.
thermodynamics in drug discovery, Drug Discovery Today,
2005, 10, 1543–1550.
17 T. G. Davies and M. Hyvönen, Fragment-based drug discovery
and X-ray crystallography, Topics in Current Chemistry 317,
Springer, 2012.
10 A. E. DeBarber, K. Mdluli, M. Bosman, L. G. Bekker and
C. E. Barry 3rd, Ethionamide activation and sensitivity
in multidrug-resistant Mycobacterium tuberculosis, Proc. 18 S. Surade, N. Ty, N. Hengrung, B. Lechartier, S. T. Cole,
Natl. Acad. U. S. A., 2000, 97, 9677–9682.
11 J. Engohang-Ndong, D. Baillat,
C. Abell and T. L. Blundell, A structure-guided fragment-
based approach for the discovery of allosteric inhibitors tar-
geting the lipophilic binding site of transcription factor
EthR, Biochem. J., 2014, 458, 387–394.
M.
Aumercier,
F. Bellefontaine, G. S. Besra, C. Locht and A. R. Baulard,
EthR, a repressor of the TetR/CamR family implicated in
ethionamide resistance in mycobacteria, octamerizes co- 19 S. K. Anandan, Z.-Y. Xiao, D. V. Patel and J. S. Ward, US Pat.
operatively on its operator, Mol. Microbiol., 2004, 51, 175–
188.
12 M. Flipo, M. Desroses, N. Lecat-Guillet, B. Dirié, X. Carette,
F. Leroux, C. Piveteau, F. Demirkaya, Z. Lens, P. Rucktooa,
V. Villeret, T. Christophe, H. K. Jeon, C. Locht, P. Brodin,
Appl. Publ., US 20050234033, 2005.
20 A. El-Faham, R. S. Funosas, R. Prohens and F. Albericio,
COMU: a safer and more effective replacement for benzo-
triazole-based uronium coupling reagents, Chem. – Eur. J.,
2009, 15, 9404–9416.
B. Déprez, A. R. Baulard and N. Willand, Ethionamide 21 S. Hardy and S. F. Martin, Multicomponent assembly and
boosters: synthesis, biological activity, and structure –
activity relationships of a series of 1,2,4-oxadiazole EthR
inhibitors, J. Med. Chem., 2011, 54, 2994–3010.
diversification of novel heterocyclic scaffolds derived from
2-arylpiperidines, Org. Lett., 2011, 13, 3102–3105.
22 R. P. Tangallapally, R. Yendapally, R. E. Lee,
A. J. M. Lenaerts and R. E. Lee, Synthesis and evaluation of
cyclic secondary amine substituted phenyl and benzyl
nitrofuranyl amides as novel antituberculosis agents,
J. Med. Chem., 2005, 48, 8261–8269.
13 M. Flipo, M. Desroses, N. Lecat-Guillet, B. Villemagne,
N. Blondiaux, F. Leroux, C. Piveteau, V. Mathys,
M.-P. Flament, J. Siepmann, V. Villeret, A. Wohlkönig,
R. Wintjens, S. H. Soror, T. Christophe, H. K. Jeon,
2326 | Org. Biomol. Chem., 2016, 14, 2318–2326
This journal is © The Royal Society of Chemistry 2016